about
Pleiotropic effects of statins in the diseases of the liverAssociation between hepatitis B and metabolic syndrome: Current state of the artHepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study.Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern SlovakiaCirculating markers of liver fibrosis progression.Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.Seroprevalence of human Toxocara infections in the Roma and non-Roma populations of Eastern Slovakia: a cross-sectional study.Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).A Community-Based Study to Estimate the Seroprevalence of Trichinellosis and Echinococcosis in the Roma and Non-Roma Population of Slovakia.Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.Mortality Amenable to Health Care in European Union Countries and Its Limitations.Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia.Exposure to Toxoplasma gondii in the Roma and Non-Roma Inhabitants of Slovakia: A Cross-Sectional Seroprevalence Study.Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia.Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in EuropeGlucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting AntiviralsChronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyNoninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance ImagingSerum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.Serum sodium identifies patients with cirrhosis at high risk of hepatorenal syndromePredictors of hepatorenal syndrome in alcoholic liver cirrhosisOn the Structure of Mortality among the Regions in the Slovak RepublicNew therapeutic options for HCV in Central EuropeThe Roma Population Living in Segregated Settlements in Eastern Slovakia Has a Higher Prevalence of Metabolic Syndrome, Kidney Disease, Viral Hepatitis B and E, and Some Parasitic Diseases Compared to the Majority PopulationWhat is the Role of the Horizontal Transmission of Hepatitis B Virus Infection in Young Adult and Middle-Aged Roma Population Living in the Settlements in East Slovakia?Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia
P50
Q26741176-419D85C5-6AF7-41FA-8D30-BC17EB098D31Q26772343-28FDB63B-6BB1-4FFA-9D8D-B5DB9868ABADQ35085804-D11624BD-1FCE-4B58-8908-BC91B5E4650AQ36453672-F602797C-7E79-4683-996A-2D3E154096DEQ37732860-177B9341-7E36-4091-A842-53DABDB12B77Q41072583-C8BCA1C6-B313-46D2-9FF2-04FA5C9B4811Q41542187-020D2804-3CCF-4BB3-9428-85BCE2ADD8C3Q46557848-1466E27E-20BE-4E08-9A5A-1DEA332429A1Q48114781-AF8E8570-14DE-46C8-AE42-E6539E5C1717Q51662386-AEF21803-ABB1-4803-8F50-1A937C67EFFBQ52663275-C5BAF172-FF86-4680-BAB1-5078383B292FQ54214343-43C2AF66-AF57-4E8F-A41E-DA16EAD9CEF3Q54263972-5C92A7E8-BCE2-4524-BFB7-13A2A13AFFFDQ54990410-F65CB616-33DE-41B4-B262-A4DB25350048Q58560215-0C2AD2DF-3CCB-4A3B-9DA0-21399BB1A66EQ58584900-3C8C0819-1A92-41E9-90AD-95F326ECFC95Q58785077-0947EE62-B446-447A-8E17-4CDFEEAD3B43Q64090067-00C7F34F-D1D4-498E-B403-49C9FAEED2A8Q64890713-88DDDCDA-6F9B-4B55-9E5E-65A43E9CF71AQ86838077-401BCF0B-F5EE-46BA-91CF-C69F882E781AQ87015404-C6A67C9F-7D86-4FCE-99FE-D0A579EDC3ECQ88014113-321E5B8B-B47A-4562-866F-4409B40B435EQ88881094-30042BDA-161C-452C-84B0-DC57AA9D46CEQ94514894-670E8929-1379-490B-BA73-13E452868160Q94591127-2836500D-A8B1-4524-9D1D-E0094228311AQ96157020-E641ECC7-2669-468A-9C47-4F55266B88D7
P50
description
researcher ORCID ID = 0000-0002-3329-3968
@en
name
Martin Janičko
@ast
Martin Janičko
@en
Martin Janičko
@es
Martin Janičko
@nl
type
label
Martin Janičko
@ast
Martin Janičko
@en
Martin Janičko
@es
Martin Janičko
@nl
prefLabel
Martin Janičko
@ast
Martin Janičko
@en
Martin Janičko
@es
Martin Janičko
@nl
P1153
24080014400
P31
P496
0000-0002-3329-3968